Unjha Formulations Share Price

  • 28.000.00 (0.00%)
  • Volume: 2,702
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:16 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Unjha Formulations Shar...

  • 28.000.00 (0.00%)
  • Volume: 2,702
Advertisment

Unjha Form share price insights

View All

  • Company has no debt since last 5 years. (Source: Standalone Financials)

  • Company's annual revenue growth of 40.37% outperformed its 3 year CAGR of 21.84%. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 3.19% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Unjha Formulations Ltd. share price remain unchanged from its previous close of Rs 28.00. Unjha Formulations Ltd. stock last traded price is 28.00

    Share PriceValue
    Today/Current/Last-28.00
    Previous Day-28.00

InsightsUnjha Form

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		15.77
    EPS - TTM
    (₹)    		1.78
    MCap
    (₹ Cr.)    		12.55
    Sectoral MCap Rank
    		164
    PB Ratio
    (x)    		4.59
    Div Yield
    (%)    		0.00
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month-0.04
    3 Months-0.24
    6 Months-0.08
    1 Year-0.04
    3 Years0.16

    		-0.04
    VWAP
    (₹)    		28.02
    52W H/L
    (₹)
    34.99 / 12.30

    Unjha Form Share Price Returns

    1 Day0.0%
    1 Week3.28%
    1 Month21.69%
    3 Months0.04%
    1 Year113.9%
    3 Years190.46%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Unjha Form belongs to analysts' top-rated companies list?

    View Stock Screeners

    Unjha Form News & Analysis

    View all Unjha Form Share News & Announcements

    Unjha Form Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Unjha Form Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Unjha Form Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 40.37% outperformed its 3 year CAGR of 21.84%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 3.19% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income3.954.445.544.773.75
      Total Income Growth (%)-10.92-19.9316.2127.0732.08
      Total Expenses3.254.395.154.893.57
      Total Expenses Growth (%)-25.87-14.825.4936.9120.08
      EBIT0.700.050.39-0.120.19
      EBIT Growth (%)1,345.87-87.58--162.44-
      Profit after Tax (PAT)0.70-0.180.39-0.120.18
      PAT Growth (%)--145.06--164.44-
      EBIT Margin (%)17.701.097.03-2.434.94
      Net Profit Margin (%)17.67-3.947.01-2.454.83
      Basic EPS (₹)1.56-0.390.87-0.260.40
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue18.5113.1814.3510.1710.86
      Total Revenue Growth (%)40.37-8.1341.08-6.31-5.78
      Total Expenses18.0612.8514.0510.0710.55
      Total Expenses Growth (%)40.46-8.5139.56-4.55-6.01
      Profit after Tax (PAT)0.280.280.250.100.31
      PAT Growth (%)-1.5911.86143.82-66.422.70
      Operating Profit Margin (%)2.732.943.042.754.00
      Net Profit Margin (%)1.502.141.781.042.90
      Basic EPS (₹)0.620.630.560.230.69

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Insights

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets4.933.413.453.533.72
      Total Assets Growth (%)44.57-1.16-2.27-5.111.92
      Total Liabilities2.200.961.281.611.90
      Total Liabilities Growth (%)129.17-25.00-20.50-15.26-11.63
      Total Equity2.732.452.171.921.81
      Total Equity Growth (%)11.4312.9013.026.0819.87
      Current Ratio (x)1.742.421.861.491.35
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities-----

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 0.11 cr for investing activities which is an YoY increase of 5.11%. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities1.03-0.310.28-0.700.29
      Net Cash used in Investing Activities-0.11-0.10-0.02-0.06-
      Net Cash flow from Financing Activities-0.05----
      Net Cash Flow0.86-0.420.26-0.770.29
      Closing Cash & Cash Equivalent0.870.010.430.170.94
      Closing Cash & Cash Equivalent Growth (%)8,647.00-97.65149.01-81.7744.48
      Total Debt/ CFO (x)0.000.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)10.1711.5111.625.3916.99
      Return on Capital Employed (%)18.4915.7919.8914.3123.40
      Return on Assets (%)5.638.287.302.938.30
      Interest Coverage Ratio (x)10.798.013.841.613.65
      Asset Turnover Ratio (x)4.433.834.06282.29285.36
      Price to Earnings (x)30.4919.8416.6936.908.36
      Price to Book (x)3.102.281.941.991.42
      EV/EBITDA (x)12.9312.057.4410.223.25
      EBITDA Margin (%)3.173.523.583.574.75

      No reported Financial Ratios are available.

    Financial InsightsUnjha Form

    • Income (P&L)
    • Balance Sheet
    • Cash Flow

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 40.37% outperformed its 3 year CAGR of 21.84%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 3.19% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Zero Debt Burden

        Company has no debt since last 5 years. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 0.11 cr for investing activities which is an YoY increase of 5.11%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Unjha Form Peer Comparison

    • Unjha Form Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Unjha Form15.774.5910.1718.495.6321.842.731.500.621.740.000.00
          Ortin Labs-2.136.16-284.74-144.81-122.01-34.45-312.19-380.81-9.893.110.64-0.49
          Beryl Drugs26.681.810.000.000.0023.588.506.211.960.000.005.03
          Norris Medicine-15.99-1.100.00-14.67-8.38-22.59-12.91-21.05-1.190.67-1.5863.68
          Parmax Pharma-3.04132.14-5,458.99-82.27-37.51-24.76-45.54-52.02-15.370.6356.07-30.10
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Colinz Labs
          • Chemo Pharma
          • Kamron Labs.
          • Bacil Pharma
          • Welcure Drugs

          Choose from Stocks

            See All Parameters

          Peers InsightsUnjha Form

            Do you find these insights useful?

            • hate it

            • meh

            • love it

            Unjha Form Shareholding Pattern

            • QOQ Change

            • Total Shareholdings

            • Loading...
              Showing Unjha Form Shareholding as on 30 Jun 2024
              Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
              Promoters36.9236.9236.9236.92
              Pledge0.000.000.000.00
              FII0.000.000.000.00
              DII0.000.000.000.00
              Mutual Funds0.000.000.000.00
              Others63.0863.0863.0863.08
            • Showing Shareholding as on 30 Jun 2024
              CategoryNo. of SharesPercentage% Change QoQ
              Promoters16,54,42436.92 %0.00
              Pledge00.00 %0.00
              Others28,26,07663.08 %0.00

            MF Ownership

            MF Ownership details are not available.

            Top Searches:

            Unjha Form News Unjha Form Quarterly Results Unjha Form Dividend Unjha Form Q1 ResultsUnjha Form Q2 ResultsUnjha Form Q3 ResultsUnjha Form Q4 Results

            Corporate Actions

            • Unjha Form Board Meeting/AGM

            • Unjha Form Dividends

            • Others
            • Meeting DateAnnounced onPurposeDetails
              Aug 01, 2024Jul 19, 2024Board MeetingQuarterly Results
              May 17, 2024May 08, 2024Board MeetingAudited Results
              Mar 29, 2024Mar 26, 2024Board MeetingOthers
              Jan 29, 2024Jan 18, 2024Board MeetingQuarterly Results
              Nov 09, 2023Oct 23, 2023Board MeetingQuarterly Results
            • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
              Final0%0.0Sep 17, 2004Jun 28, 2004
              Final0%0.0Sep 09, 2002Sep 18, 2002
              Final0%0.0Sep 09, 2002Jul 18, 2002

            • No other corporate actions details are available.

            About Unjha Form

            Unjha Formulations Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 12.76 Crore) operating in Pharmaceuticals sector. Unjha Formulations Ltd. key Products/Revenue Segments include Ayurvedic Products, Husk, Anchor, Veterinary Products, Other Sales, Packing Materials & Others, Allopathic Medicine for the year ending 31-Mar-2024. Show More

            • Executives

            • Auditors

            • JS

              Jashodaben S Patel

              Chairman
              KM

              Krutiben M Patel

              Managing Director
              EM

              Esha M Patel

              Director
              HS

              Hashmukh S Darji

              Director
              Show More
            • Jain & Golechha
              Milind Shah & Co.

            Industry

            Pharma - Indian

            Key Indices Listed on

            -

            Address

            Khali Char Rasta,State HighwaySidhpur, Gujarat - 384151

            Contact

            [email protected]

            http://www.unjhaformulations.com

            More Details

            FAQs about Unjha Form share

            • 1. What is Unjha Form share price and what are the returns for Unjha Form share?
              As on 29 Aug, 2024, 03:16 PM IST Unjha Form share price was remain unchanged by 0.00% basis the previous closing price of Rs 27.6. Unjha Form share price was Rs 28.00. Return Performance of Unjha Form Shares:
              • 1 Week: Unjha Form share price moved up by 3.28%
              • 3 Month: Unjha Form share price moved up by 0.04%
            • 2. What's the market capitalization of Unjha Form?
              Unjha Form share has a market capitalization of Rs 12.55 Cr. Within Pharmaceuticals sector, it's market cap rank is 164.
            • 3. Who's the owner of Unjha Form?
                • Promoter holding has not changed in last 9 months and holds 36.92 stake as on 30 Jun 2024
                • Other investor holding has not changed in last 9 months and holds 63.08 stake as on 30 Jun 2024
            • 4. What is the CAGR of Unjha Form?
              The CAGR of Unjha Form is 16.75.
            • 5. What is 52 week high/low of Unjha Form share price?
              In last 52 weeks Unjha Form share had a high price of Rs 34.99 and low price of Rs 12.30
            • 6. What is the PE & PB ratio of Unjha Form?
              The PE ratio of Unjha Form stands at 15.77, while the PB ratio is 4.59.
            • 7. What are the Unjha Form quarterly results?
              Total Revenue and Earning for Unjha Form for the year ending 2024-03-31 was Rs 18.51 Cr and Rs 0.28 Cr on Standalone basis. Last Quarter 2024-06-30, Unjha Form reported an income of Rs 3.95 Cr and profit of Rs 0.70 Cr.
            • 8. Who are the peers for Unjha Form in Pharmaceuticals sector?
              Top 10 Peers for Unjha Form are Parmax Pharma Ltd., Bacil Pharma Ltd., Welcure Drugs & Pharmaceuticals Ltd., Norris Medicines Ltd., Chemo Pharma Laboratories Ltd., Colinz Laboratories Ltd., Beryl Drugs Ltd., Kobo Biotech Ltd., Adline Chem Lab Ltd. and Ortin Laboratories Ltd.
            • 9. Is Unjha Form giving dividend?
              Unjha Formulations Ltd. announced an equity dividend of 0% on a face value of 10.0 amounting to Rs 0 per share on 28 Jun 2004. The ex dividend date was 17 Sep 2004.
            • 10. What are the returns for Unjha Form share?
              Return Performance of Unjha Form Shares:
              • 1 Week: Unjha Form share price moved up by 3.28%
              • 3 Month: Unjha Form share price moved up by 0.04%
            • 11. Who is the chairman of Unjha Form?
              Jashodaben S Patel is the Chairman of Unjha Form
            • 12. How can I quickly analyze Unjha Form stock?
              Key Metrics for Unjha Form are:
              • PE Ratio of Unjha Form is 15.77
              • Price/Sales ratio of Unjha Form is 0.46
              • Price to Book ratio of Unjha Form is 4.59

            Trending in Markets

            DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

            DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

            By using this site, you agree to the Terms of Service and Privacy Policy.

            Business News›Markets›Stocks›Stock Price Quotes›Unjha Form Share Price
            The Economic Times